General Medicine and Primary Care

1-16 of 24

• 

  RestartResume

  Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  

  RestartResume

  Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  

  MinuteCE®

  Diagnosing IBD: Is It IBD or Something Else? Can You Tell?  

  1.00 program credit

  • 

    

    Kimberly D. Orleck, PA-C

  • 

    

    Jennifer Geremia, PA-C

  1.00 program credit

• 

  RestartResume

  Severity Assessment: Can You Pin the Stage on the Patient?

  RestartResume

  Severity Assessment: Can You Pin the Stage on the Patient?

  MinuteCE®

  Severity Assessment: Can You Pin the Stage on the Patient?

  1.00 program credit

  • 

    

    Jennifer Geremia, PA-C

  • 

    

    Brooke Hodnick, PA-C, MPAS

  1.00 program credit

• 

  RestartResume

  IBD Immunopathogenesis: Do You Know What You're Blocking?

  RestartResume

  IBD Immunopathogenesis: Do You Know What You're Blocking?

  MinuteCE®

  IBD Immunopathogenesis: Do You Know What You're Blocking?

  1.00 program credit

  • 

    

    Kimberly D. Orleck, PA-C

  • 

    

    Brooke Hodnick, PA-C, MPAS

  1.00 program credit

• 

  RestartResume

  Tailoring Treatment: Can You Select the Best Therapy? 

  RestartResume

  Tailoring Treatment: Can You Select the Best Therapy? 

  MinuteCE®

  Tailoring Treatment: Can You Select the Best Therapy? 

  1.00 program credit

  • 

    

    David Rubin, MD

  • 

    

    Brooke Hodnick, PA-C, MPAS

  1.00 program credit

• 

  RestartResume

  Case Review: Can You Crack This IBD Case? 

  RestartResume

  Case Review: Can You Crack This IBD Case? 

  MinuteCE®

  Case Review: Can You Crack This IBD Case? 

  1.00 program credit

  • 

    

    David Rubin, MD

  • 

    

    Kimberly D. Orleck, PA-C

  1.00 program credit

• 

  RestartResume

  Treat-to-Target: Are We There Yet? 

  RestartResume

  Treat-to-Target: Are We There Yet? 

  MinuteCE®

  Treat-to-Target: Are We There Yet? 

  1.00 program credit

  • 

    

    Kimberly D. Orleck, PA-C

  • 

    

    Jennifer Geremia, PA-C

  1.00 program credit

• 

  RestartResume

  Remission: Can You Prove It? 

  RestartResume

  Remission: Can You Prove It? 

  MinuteCE®

  Remission: Can You Prove It? 

  1.00 program credit

  • 

    

    David Rubin, MD

  • 

    

    Kimberly D. Orleck, PA-C

  1.00 program credit

• 

  RestartResume

  Switching Strategies: Switch or Stay—What’s Your Call? 

  RestartResume

  Switching Strategies: Switch or Stay—What’s Your Call? 

  MinuteCE®

  Switching Strategies: Switch or Stay—What’s Your Call? 

  1.00 program credit

  • 

    

    David Rubin, MD

  • 

    

    Brooke Hodnick, PA-C, MPAS

  1.00 program credit

• 

  RestartResume

  Case Review: Targets Are Met—Can You Stick the Landing? 

  RestartResume

  Case Review: Targets Are Met—Can You Stick the Landing? 

  MinuteCE®

  Case Review: Targets Are Met—Can You Stick the Landing? 

  1.00 program credit

  • 

    

    David Rubin, MD

  • 

    

    Jennifer Geremia, PA-C

  1.00 program credit

• 

  RestartResume

  Updates in Major Depressive Disorder with Insomnia

  RestartResume

  Updates in Major Depressive Disorder with Insomnia

  CME/CE

  Updates in Major Depressive Disorder with Insomnia

  0.50 credits

  • 

    

    Michael E. Thase, MD

  • 

    

    Andrew Krystal, MD

  0.50 credits

• 

  RestartResume

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  RestartResume

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  CME/CE

  Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia

  0.25 credits

  • 

    

    Christoph U. Correll, MD

  • 

    

    Jonathan M. Meyer

  0.25 credits

• 

  RestartResume

  Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study

  RestartResume

  Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study

  Psychiatry and Mental Health

  Valbenazine and Patient-Centered Outcomes in TD: Insights From the KINECT-PRO Study

  • 

    

    Christoph U. Correll, MD

• 

  RestartResume

  Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4

  RestartResume

  Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4

  Psychiatry and Mental Health

  Valbenazine for TD: Consistent Long-Term Efficacy Across Racial and Ethnic Subgroups in KINECT-4

  • 

    

    Jonathan M. Meyer, MD

• 

  MinuteCE®

  AF and VTE: Global Considerations in the Evolving Space of Real-World Data

  1.00 credit 10 episodes

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  • 

    

    Valeria Caso, MD, PhD

  • 

    

    Alexander T. Cohen, MD, MBBS

  1.00 credit 10 episodes

• 

  RestartResume

  Setting the Stage of Real-World Data vs RCT

  RestartResume

  Setting the Stage of Real-World Data vs RCT

  MinuteCE®

  Setting the Stage of Real-World Data vs RCT

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  1.00 program credit

• 

  RestartResume

  Trade off: Ischemic/Thrombotic vs Bleeding  

  RestartResume

  Trade off: Ischemic/Thrombotic vs Bleeding  

  MinuteCE®

  Trade off: Ischemic/Thrombotic vs Bleeding  

  1.00 program credit

  • 

    

    Renato D. Lopes, MD, MHS, PhD

  1.00 program credit